IL6 and neoplasm: Li et al. reported that tumor-derived lactate in CRC enhances H3K18la, suppresses RARγ transcription, elevates IL-6 levels in the TME, and activates STAT3 signaling, endowing macrophages with pro-tumor functions 86.